Zimmer Biomet Holdings ROE 2006-2020 | ZBH
Current and historical return on equity (ROE) values for Zimmer Biomet Holdings (ZBH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Zimmer Biomet Holdings ROE for the three months ending March 31, 2020 was 13.29%.
| Zimmer Biomet Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2020-03-31 | $0.38B | $11.88B | 3.14% |
| 2019-12-31 | $1.13B | $12.39B | 9.50% |
| 2019-09-30 | $-0.09B | $12.09B | -0.77% |
| 2019-06-30 | $-0.36B | $11.66B | -3.07% |
| 2019-03-31 | $-0.31B | $11.54B | -2.62% |
| 2018-12-31 | $-0.38B | $11.28B | -3.19% |
| 2018-09-30 | $1.75B | $12.22B | 14.61% |
| 2018-06-30 | $1.69B | $12.04B | 14.62% |
| 2018-03-31 | $1.69B | $12.00B | 15.19% |
| 2017-12-31 | $1.81B | $11.74B | 17.10% |
| 2017-09-30 | $0.65B | $10.45B | 6.47% |
| 2017-06-30 | $0.71B | $10.28B | 7.19% |
| 2017-03-31 | $0.50B | $9.93B | 5.11% |
| 2016-12-31 | $0.31B | $9.67B | 3.18% |
| 2016-09-30 | $0.36B | $9.75B | 3.75% |
| 2016-06-30 | $0.23B | $9.55B | 2.32% |
| 2016-03-31 | $0.08B | $9.66B | 0.85% |
| 2015-12-31 | $0.15B | $9.89B | 1.60% |
| 2015-09-30 | $0.17B | $9.99B | 2.02% |
| 2015-06-30 | $0.32B | $10.13B | 4.28% |
| 2015-03-31 | $0.67B | $6.58B | 10.26% |
| 2014-12-31 | $0.72B | $6.55B | 11.19% |
| 2014-09-30 | $0.83B | $6.54B | 12.96% |
| 2014-06-30 | $0.81B | $6.45B | 12.86% |
| 2014-03-31 | $0.78B | $6.24B | 12.75% |
| 2013-12-31 | $0.78B | $6.30B | 12.98% |
| 2013-09-30 | $0.68B | $6.14B | 11.49% |
| 2013-06-30 | $0.70B | $5.89B | 12.05% |
| 2013-03-31 | $0.77B | $5.71B | 13.23% |
| 2012-12-31 | $0.76B | $5.87B | 13.11% |
| 2012-09-30 | $0.76B | $5.83B | 13.38% |
| 2012-06-30 | $0.77B | $5.71B | 13.76% |
| 2012-03-31 | $0.76B | $5.66B | 13.38% |
| 2011-12-31 | $0.76B | $5.52B | 13.25% |
| 2011-09-30 | $0.64B | $5.61B | 11.01% |
| 2011-06-30 | $0.64B | $6.02B | 10.89% |
| 2011-03-31 | $0.60B | $5.86B | 10.37% |
| 2010-12-31 | $0.60B | $5.77B | 10.36% |
| 2010-09-30 | $0.72B | $5.82B | 12.52% |
| 2010-06-30 | $0.68B | $5.74B | 11.72% |
| 2010-03-31 | $0.72B | $5.71B | 12.45% |
| 2009-12-31 | $0.72B | $5.64B | 12.48% |
| 2009-09-30 | $0.73B | $5.98B | 12.70% |
| 2009-06-30 | $0.80B | $5.81B | 14.05% |
| 2009-03-31 | $0.81B | $5.56B | 14.54% |
| 2008-12-31 | $0.85B | $5.65B | 15.10% |
| 2008-09-30 | $0.95B | $5.62B | 16.96% |
| 2008-06-30 | $0.78B | $5.51B | 14.15% |
| 2008-03-31 | $0.78B | $5.71B | 14.38% |
| 2007-12-31 | $0.77B | $5.45B | 14.67% |
| 2007-09-30 | $0.76B | $5.25B | 14.68% |
| 2007-06-30 | $0.89B | $5.28B | 17.75% |
| 2007-03-31 | $0.86B | $5.12B | 17.47% |
| 2006-12-31 | $0.84B | $4.92B | 17.09% |
| 2006-09-30 | $0.79B | $4.80B | 16.37% |
| 2006-06-30 | $0.78B | $4.90B | 16.33% |
| 2006-03-31 | $0.77B | $4.92B | 16.64% |
| 2005-12-31 | $0.73B | $4.68B | 16.64% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $24.894B | $7.982B |
| Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The company design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. Zimmer Biomet Holdings, Inc., formerly known as Zimmer Holdings, Inc., is based in Warsaw, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $163.141B | 28.29 |
| Medtronic (MDT) | Ireland | $124.955B | 20.30 |
| Stryker (SYK) | United States | $68.946B | 22.38 |
| Boston Scientific (BSX) | United States | $49.509B | 23.28 |
| Baxter (BAX) | United States | $44.233B | 27.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $39.871B | 0.00 |
| Terumo (TRUMY) | Japan | $29.963B | 38.30 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $28.693B | 0.00 |
| ResMed (RMD) | United States | $27.846B | 43.95 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $17.257B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $16.924B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $13.589B | 61.86 |
| Insulet (PODD) | United States | $12.687B | 1256.94 |
| DiaSorin S.p.A (DSRLF) | Italy | $10.994B | 0.00 |
| Quidel (QDEL) | United States | $9.535B | 74.93 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $8.773B | 0.00 |
| Perrigo (PRGO) | Ireland | $7.523B | 13.46 |
| Hill-Rom Holdings (HRC) | United States | $7.426B | 20.93 |
| GN STORE NORD (GNNDY) | Denmark | $6.972B | 0.00 |
| William Demant Holdings (WILYY) | Denmark | $6.296B | 0.00 |
| Canopy Growth (CGC) | Canada | $5.771B | 0.00 |
| Haemonetics (HAE) | United States | $4.656B | 27.96 |
| Neogen (NEOG) | United States | $4.108B | 69.58 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.892B | 0.00 |
| ICU Medical (ICUI) | United States | $3.890B | 28.38 |
| Agios Pharmaceuticals (AGIO) | United States | $3.836B | 0.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.805B | 0.00 |
| Envista Holdings (NVST) | United States | $3.407B | 0.00 |
| NuVasive (NUVA) | United States | $2.925B | 23.49 |
| National Vision Holdings (EYE) | United States | $2.458B | 42.53 |
| TG Therapeutics (TGTX) | United States | $2.213B | 0.00 |
| AtriCure (ATRC) | United States | $1.855B | 0.00 |
| MacroGenics (MGNX) | United States | $1.450B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $1.390B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.322B | 0.00 |
| Aphria (APHA) | Canada | $1.231B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.137B | 0.00 |
| Cerus (CERS) | United States | $1.109B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.055B | 21.02 |
| Meridian Bioscience (VIVO) | United States | $1.019B | 38.37 |
| PetIQ (PETQ) | United States | $1.017B | 29.37 |
| DFB Healthcare Acquisitions (AHCO) | United States | $0.924B | 153.85 |
| InMode (INMD) | Israel | $0.897B | 18.97 |
| Vapotherm (VAPO) | United States | $0.881B | 0.00 |
| Zynex (ZYXI) | United States | $0.834B | 83.73 |
| Omeros (OMER) | United States | $0.826B | 0.00 |
| Quanterix (QTRX) | United States | $0.789B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.746B | 150.25 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.663B | 47.51 |
| Surmodics (SRDX) | United States | $0.585B | 70.49 |
| VAREX IMAGING (VREX) | United States | $0.584B | 14.50 |
| Lantheus Holdings (LNTH) | United States | $0.579B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $0.532B | 30.29 |
| BioLife Solutions (BLFS) | United States | $0.467B | 163.45 |
| Owens & Minor (OMI) | United States | $0.464B | 12.27 |
| Repro-Med Systems (KRMD) | United States | $0.394B | 302.33 |
| Viemed Healthcare (VMD) | United States | $0.367B | 32.55 |
| Cytosorbents (CTSO) | United States | $0.361B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.315B | 22.85 |
| HEXO (HEXO) | $0.311B | 0.00 | |
| Neptune Wellness Solutions (NEPT) | Canada | $0.304B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.285B | 0.00 |
| Female Health (VERU) | United States | $0.229B | 0.00 |
| Chimerix (CMRX) | United States | $0.196B | 0.00 |
| Bovie Medical (APYX) | United States | $0.185B | 0.00 |
| Evolus (EOLS) | United States | $0.185B | 0.00 |
| Surface Oncology (SURF) | United States | $0.178B | 0.00 |
| Exagen (XGN) | United States | $0.161B | 0.00 |
| Fonar (FONR) | United States | $0.135B | 11.94 |
| Rockwell Medical (RMTI) | United States | $0.133B | 0.00 |
| United Health Products (UEEC) | United States | $0.131B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.120B | 0.00 |
| Wound Management Technologies (SMTI) | United States | $0.112B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.109B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.103B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.084B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.082B | 0.00 |
| Nephros (NEPH) | United States | $0.073B | 0.00 |
| United-Guardian (UG) | United States | $0.071B | 16.51 |
| Capricor Therapeutics (CAPR) | United States | $0.065B | 0.00 |
| Brainsway (BWAY) | Israel | $0.065B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.036B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.027B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.022B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.017B | 0.00 |
| Conatus Pharmaceuticals (HSTO) | United States | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
